A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions....
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/full |
id |
doaj-1185bcdf92cb40acb20cd46fb2d351f0 |
---|---|
record_format |
Article |
spelling |
doaj-1185bcdf92cb40acb20cd46fb2d351f02020-11-25T00:46:27ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2019-01-01510.3389/fcvm.2018.00189432204A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on FunctionAshley Mulchrone0Heidi B. Kellihan1Omid Forouzan2Timothy A. Hacker3Melissa L. Bates4Melissa L. Bates5Christopher J. Francois6Naomi C. Chesler7Naomi C. Chesler8Department of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesSchool of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Health and Human Physiology, University of Iowa, Iowa City, IA, United StatesDepartment of Pediatrics, University of Iowa, Iowa City, IA, United StatesDepartment of Radiology, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, United StatesChronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions. Large animal models enable the use of clinical techniques and technologies to assess progression and diagnose failure, but the existing large animal models of CTEPH have not been shown to replicate the functional consequences of the RV, i.e., RV failure. Here, we created a canine embolization model of CTEPH utilizing only microsphere injections, and we used a combination of right heart catheterization (RHC), echocardiography (echo), and magnetic resonance imaging (MRI) to quantify RV function. Over the course of several months, CTEPH led to a 6-fold increase in pulmonary vascular resistance (PVR) in four adult, male beagles. As evidenced by decreased cardiac index (0.12 ± 0.01 v. 0.07 ± 0.01 [L/(min*kg)]; p < 0.05), ejection fraction (0.48 ± 0.02 v. 0.31 ± 0.02; p < 0.05), and ventricular-vascular coupling ratio (0.95 ± 0.09 v. 0.45 ± 0.05; p < 0.05), as well as decreased tricuspid annular plane systolic excursion (TAPSE) (1.37 ± 0.06 v. 0.86 ± 0.05 [cm]; p < 0.05) and increased end-diastolic volume index (2.73 ± 0.06 v. 2.98 ± 0.02 [mL/kg]; p < 0.05), the model caused RV failure. The ability of this large animal CTEPH model to replicate the hemodynamic consequences of the human disease suggests that it could be utilized for future studies to gain insight into the pathophysiology of CTEPH development, following further optimization.https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/fullpulmonary embolizationpulmonary hemodynamicsright ventricular afterloadeffective arterial elastance (Ea)pulmonary vascular resistance (PVR) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashley Mulchrone Heidi B. Kellihan Omid Forouzan Timothy A. Hacker Melissa L. Bates Melissa L. Bates Christopher J. Francois Naomi C. Chesler Naomi C. Chesler |
spellingShingle |
Ashley Mulchrone Heidi B. Kellihan Omid Forouzan Timothy A. Hacker Melissa L. Bates Melissa L. Bates Christopher J. Francois Naomi C. Chesler Naomi C. Chesler A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function Frontiers in Cardiovascular Medicine pulmonary embolization pulmonary hemodynamics right ventricular afterload effective arterial elastance (Ea) pulmonary vascular resistance (PVR) |
author_facet |
Ashley Mulchrone Heidi B. Kellihan Omid Forouzan Timothy A. Hacker Melissa L. Bates Melissa L. Bates Christopher J. Francois Naomi C. Chesler Naomi C. Chesler |
author_sort |
Ashley Mulchrone |
title |
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
title_short |
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
title_full |
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
title_fullStr |
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
title_full_unstemmed |
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
title_sort |
large animal model of right ventricular failure due to chronic thromboembolic pulmonary hypertension: a focus on function |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cardiovascular Medicine |
issn |
2297-055X |
publishDate |
2019-01-01 |
description |
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions. Large animal models enable the use of clinical techniques and technologies to assess progression and diagnose failure, but the existing large animal models of CTEPH have not been shown to replicate the functional consequences of the RV, i.e., RV failure. Here, we created a canine embolization model of CTEPH utilizing only microsphere injections, and we used a combination of right heart catheterization (RHC), echocardiography (echo), and magnetic resonance imaging (MRI) to quantify RV function. Over the course of several months, CTEPH led to a 6-fold increase in pulmonary vascular resistance (PVR) in four adult, male beagles. As evidenced by decreased cardiac index (0.12 ± 0.01 v. 0.07 ± 0.01 [L/(min*kg)]; p < 0.05), ejection fraction (0.48 ± 0.02 v. 0.31 ± 0.02; p < 0.05), and ventricular-vascular coupling ratio (0.95 ± 0.09 v. 0.45 ± 0.05; p < 0.05), as well as decreased tricuspid annular plane systolic excursion (TAPSE) (1.37 ± 0.06 v. 0.86 ± 0.05 [cm]; p < 0.05) and increased end-diastolic volume index (2.73 ± 0.06 v. 2.98 ± 0.02 [mL/kg]; p < 0.05), the model caused RV failure. The ability of this large animal CTEPH model to replicate the hemodynamic consequences of the human disease suggests that it could be utilized for future studies to gain insight into the pathophysiology of CTEPH development, following further optimization. |
topic |
pulmonary embolization pulmonary hemodynamics right ventricular afterload effective arterial elastance (Ea) pulmonary vascular resistance (PVR) |
url |
https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/full |
work_keys_str_mv |
AT ashleymulchrone alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT heidibkellihan alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT omidforouzan alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT timothyahacker alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT melissalbates alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT melissalbates alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT christopherjfrancois alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT naomicchesler alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT naomicchesler alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT ashleymulchrone largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT heidibkellihan largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT omidforouzan largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT timothyahacker largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT melissalbates largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT melissalbates largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT christopherjfrancois largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT naomicchesler largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction AT naomicchesler largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction |
_version_ |
1725265366830022656 |